Abstract
Neural tube defects (spina bifida) are congenital anomalies that result from incomplete closure of the neural tube in utero. This chapter discusses the pathophysiology, epidemiology, medical/surgical treatments, and nursing care for patients with open neural tube defects such as myelomeningocele as well as closed neural tube defects. Results from the MOMs trial, hydrocephalus, latex precautions, bowel and bladder continence, tethered cord syndrome, and cutaneous signs of spina bifida occulta are also discussed. Parent stories are included to give a perspective about what life with a child with spina bifida is like.
Shona Lens was the author of the original chapter and 2nd edition, but did not participate in this revision.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AAP Policy Statement Committee on Genetics (1999, Reaffirmed 2012), American Academy of Pediatrics: folic acid for the prevention of neural tube defects. Pediatrics 104(2):325–327
Ackerman LL, Menezes AH (2003) Spinal congenital dermal sinuses: a 30 year experience. Pediatrics 112(3 pt 1):641–647
Adzick NS, Thom EA, Spong CY, Brock JW III, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D’Alton ME, Farmer DL (2011) A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364(11):993–1004
Adzick NS (2010) Fetal myelomeningocele: natural history, pathophysiology, and in-utero intervention. Semin Fetal Neonatal Med 15(1):9–14
Ames MD, Shut L (1972) Results of treatment of 171 consecutive myelomeningoceles, 1963 to 1968. Pediatrics 50:466–470
Anderson FM (1975) Occult spinal dysraphism. A series of 73 cases. Pediatrics 55:826–835
Anderson PA, Travers AH (1993) Development of hydronephrosis in spina bifida patients: predictive factors and management. Br J Urol 72:958–961
Betz CL, Smith KA, Van Speybroeck A, Hernandez FV, Jacobs RA (2016) Movin’ on up: an innovative nurse-led interdisciplinary health care transition program. J Pediatr Health Care 30(4):323–338
Brock JW 3rd, Carr MC, Adzick NS, Burrows PK, Thomas JC, Thom EA, Howell LJ, Farrell JA, Dabrowiak ME, Farmer DL, Cheng EY, Kropp BP, Caldamone AA, Bulas DI, Tolifaisa S, LS B, MOMS Investigators (2015) Bladder function after fetal surgery for myelomeningocele. Pediatrics 136(4):e906–e913
Canfield M, Mai C, Wang Y, O’Halloran A, Marengo L, Olney R, Borger C, Rutkowski R, Fornoff J, Irwin N, Copeland G, Flood T, Meyer R, Rickard R, Alverson C, Sweatlock J, Kirby R (2014) The association between race/ethnnicity and major birth defects in the United States, 1999–2007. AJPH 104(9):e14–e23
Centers for Disease Control and Prevention (2004) Spina bifida and anencephaly before and after folic acid mandate – United States, 1995–1996 and 1999–2000. MMWR Morb Mortal Wkly Rep 53(17):362–365
CDC (2015) Updated estimates of neural tube defects prevented by mandatory folic acid fortification – United States, 1995–2011. MMWR 64(01):1–5
Chakraborty A, Crimmins D, Hayward R, Thompson D (2008) Toward reducing shunt placement rates in patients with myelomeningocele. J Neurosurg Pediatr 1(5):361–365
Cohen AR, Robinson S (2001) Early management of myelomeningocele. In: McLone DG (ed) Pediatric neurosurgery; surgery of the developing nervous system. W.B. Saunders Company, Philadelphia, pp 241–259
Cohen SE, Hooper SR, Javalkar K, Haberman C, Fenton N, Lai H, Mahan JD, Massengill S, Kelly M, Cantú G, Medeiros M, Phillips A, Sawicki G, Wood D, Johnson M, Benton MH, Ferris M (2015) Self-management and transition readiness assessment: concurrent, predictive, and discriminant validation of the STARx questionnaire. J Pediatr Nurs 30(5):668–676
Coniglio SJ, Anderson SM, Ferguson JE (1997) Developmental outcomes of children with myelomeningocele: prenatal predictors. Am J Obstet Gynecol 177(2):319–324
d’Ercole C, Shojai R, Desbriere R, Chau C, Bretelle F, Piechon L (2003) Prenatal screening: invasive diagnostic approaches. Childs Nerv Syst 19:444–447
Danzer E, Flank AW (2008) In utero repair of myelomeningocele: rationale, initial clinical experience and a randomized controlled prospective clinical trial. Neuroembryology Aging 4:165–174
Davis AM, Brown RF, Taylor JL, Epstein RA, MPheeters MI (2014) Transition care for children with special healthcare needs. Pediatrics 134:900–908
Deak KL, Siegel DG, George TM, Gregory S, Ashley-Koch A, MC S, NTD Collaborative Group (2008) Further evidence for a maternal genetic effect and a sex-influenced effect contributing to the risk for human neural tube defects. Birth Defects Res A Clin Mol Teratol 82(10):662–669
Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC (2005) Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol 27:515–524
Dias M, Partington M (2015) Congenital brain and spinal cord malformations and their associated cutaneous markers. Pediatrics 136:e1105
Elwood JM, Little J, Elwood JH (1992) Epidemiology and control of neural tube defects. Oxford University Press, Oxford
Federal Register (2016) Food Additives Permited for Direct Human Consumption; Folic Acid 81(73):22176–83
Finer LB, Zolna MR (2016) Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med 374:843–852
Gaskill SJ (2004) Primary closure of open myelomeningocele. Neurosurg Focus 16(2):1–4
Grant RA, Heuer GG, Carrion GM, Adzick NS, Schwartz ES, Stein C, Storm PB, Sutton LN (2011) Morphometric analysis of posterior fossa after in utero myelomeningocele repair. J Neurosurg Pediatr 7(4):362–368
Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY (2001) Impact of folic acid fortification of the us food supply on the occurrence of neural tube defects. J Am Med Assoc 285(23):2981–2986
Hughes JA, De Bruyn R, Patel K, Thompson D (2003) Evaluation of spinal ultrasound in spinal dysraphism. Clin Radiol 58:227–233
James CCM, Lassman LP (1981) Spina bifida occulta: orthopaedic, radiological and neurosurgical aspects. Academic Press/Grune & Strattons, London/New York
Keating MA, Rink RC, Bauer SB (1988) Neurological implications of the changing approach in management of occult spinal lesions. J Urol 140:1299–1301
Korsvik HE, Keller MS (1992) Sonography of occult dysraphism in neonates and infants with MR imaging correlation. Radiographics 12:297–306
Lary JM, Edmonds LD (1996) Prevalence of spina bifida at birth – United States, 1983–1990: a comparison of two surveillance systems. Morb Mortal Wkly Rep Surveill Summ 45:15–26
Laurence KM (1974) Effect for early surgery for spina bifida cystica on survival and quality of life. Lancet 1:301–304
Liptak GS (1997) Neural tube defects. In: Batshaw ML (ed) Children with disabilities, 4th edn. Paul H Brookes, Baltimore, pp 529–552
Manning SM, Jennings R, Madsen JR (2000) Pathophysiology, prevention, and potential treatment of neural tube defects. Ment Retard Dev Disabil Res Rev 6:6–14
Mathews TJ, MacDorman MF, Thoma ME. Infant mortality statistics from the 2013 period linked birth/infant death data set. National vital statistics reports; vol 64 no 9. National Center for Health Statistics. 2015
Mazagri R, Ventureyra EC (1999) Latex allergy in neurosurgical practice. Childs Nerv Syst 15:404–407
McCance KM, Huether SE (2002) Pathophysiology the biologic basis for disease in adults & children, 4th edn. Mosby, St. Louis
McLone DG (1998) Care of the neonate with a myelomeningocele. In: Neurosurgery of the neonate. Neurosurg Clin North Am 9(1):111–120. Saunders, Philadelphia
Meuli M, Moehrien U (2014) Fetal surgery for myelomeningocele is effective: a critical look at the whys. Pediatr Surg Int 30(7):689–697
Munson D, Leuthner SR (2007) Palliative care for the family carrying a fetus with a life-limiting diagnosis. Pediatr Clin N Am 54:787–798
National Institute of Neurological Disorders and Stroke (n.d.) Spina bifida, retrieved 19 Sept 2016, from www.ninds.nih.gov/disorders/spina_bifida
Park TS (1999) Myelomeningocele. In: Albright AL, Pollack IF, Adelson PD (eds) Principles and practice of pediatric neurosurgery. Thieme, New York, pp 125–139
Petronio J, Walker ML (2001) Ventriculoscopy. In: McLone DG (ed) Pediatric neurosurgery; surgery of the developing nervous system. W.B. Saunders Company, Philadelphia, pp 559–562
Phillips BC, Gelsomino M, Pownall AL, Ocal E, Spencer HJ, O’Brien MS, Albert GW (2014) Predictors of the need for cerebrospinal fluid diversion in patients with myelomeningocele. J Neurosurg Pediatr 14(2):167–172
Rekate HL (1999) Treatment of hydrocephalus. In: Albright AL, Pollack IF, Adelson PD (eds) Principles and practice of pediatric neurosurgery. Thieme, New York, pp 125–139
Sakakibara R, Hattori T, Uchiyama T, Kamura K, Yamanishi T (2003) Uroneurological assessment of spina bifida cystica and occulta. Neurourol Urodyn 22:328–334
Sandler AD (2010) Children with spina bifida: key clinical issues. Pediatr Clin N Am 57:879–892
Simpson JL, Greene MF (2011) Fetal surgery for myelomeningocele? Editorial. N Engl J Med 364(11):1076–1077
Toriello HV, for the Policy and Practice Guideline Committee of the American College of Medical Genetics (2011) Policy statement on folic acid and neural tube defects. Genet Med 13(6):593–596
Tulipan N, Wellons JC 3rd, Thom EA, Gupta N, Sutton LN, Burrows PK, Farmer D, Walsh W, MP J, Rand L, Tolivaisa S, D’alton ME, Adzick DS, MOMS Investigators (2015) Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr 16(6):613–620
Warf BC (2005) Comparison of endoscopic third ventriculostomy alone and combined with choroid plexus cauterization in infants younger than 1 year of age: a prospective study in 550 African children. J Neurosurg Pediatr 103:475–481
Warf BC (2011) Hydrocephalus associated with neural tube defects: characteristics, management, and outcome in sub-Saharan Africa. Childs Nerv Syst 27(10):1589–1594
Wenstrom KD, Johanning GL, Owen J, Johnston KE, Acton S, Tamura T (2000) Role of amniotic fluid homocysteine level of fetal 5, 10-methyleneterahydrafolate reductase genotype in the etiology of neural tube defects. Am J Med Genet 90(1):12–16
Yamada S, Won DJ, Yamada SM (2004) Pathophysiology of tethered cord syndrome: correlation with symptomatology. Neurosurg Focus 16(2):1–5
Yamada S, Won DJ, Pezeshkpour G, Yamada BS, Yamada SM, Siddigi J, Zouros A, Colohan AR (2007) Pathophysiology of tethered cord syndrome and similar complex disorders. Neurosurg Focus 23(2):E6
Yen IH, Khoury MJ, Erickson JD, James LM, Waters GD, Berry RJ (1992) The changing epidemiology of neural tube defects: United States, 1968–1989. Am J Dis Child 146:857–861
Zhang T, Lou J, Zhong R, Wu J, Sun Y, Xuzai L, Liu L, Xiaoping M, Xiong G (2013) Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLoS One 8(4):e59570
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Dexter, M.L., Schultz, T. (2017). Neural Tube Defects. In: Cartwright, C., Wallace, D. (eds) Nursing Care of the Pediatric Neurosurgery Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-49319-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-49319-0_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-49318-3
Online ISBN: 978-3-319-49319-0
eBook Packages: MedicineMedicine (R0)